Hepatologist calls for action on liver disease in patients with type 2 diabetes

Endocrinologists have to step up to the challenge of managing liver disease as a comorbidity in their patients with type 2 diabetes. Speaking at the ADA 2020 virtual Scientific Sessions, Professor Kenneth Cusi said non-alcoholic fatty liver disease (NAFLD) is more common in endocrinology clinics than people realise. While the prevalence of NAFLD as indicated ...

Already a member?

Login to keep reading.

© 2021 the limbic